3Yamamoto C,Yoneda T,Yoshikawa M,et al.Airway inflammation in COPD assessed by sputum levels of interleukin-8.Chest,1997,112:505-510.
4Wiede A,Jagla W,Welte T,et al.Localization of TFF3,a new mucus-associated peptide of the human respiratory tract.Am J Respir Crit Care Med,1999,159(4 Pt 1):1330-1335.
5GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
6Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
7Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
